Project Grant HT94252410677
- This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
- This $440,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by Baylor College of Medicine in Houston, Texas to develop biopolymers for intestinal healing and immune modulation to treat inflammatory bowel disease. The award has a performance period from January 15, 2025 to January 14, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform...
- The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
- This $1,200,000.00 federal Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the development of a 3D-fabricated controlled-release drug delivery system to stimulate scarless corneal wound healing at Baylor College of Medicine in Houston, TX. The research project aims to advance innovative medical technologies that can transform healthcare for military service members and the broader public. The...
- The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader...
- This $1,200,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Baylor College of Medicine to develop an antibody nanogel that targets bone metastases. The project aims to eliminate bone metastasis, which is a significant challenge in treating various cancers. Baylor College of Medicine, a prestigious non-profit research institution, will conduct this advanced biomedical research over a 3-year...
- This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
- This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
- Federal Project Grant Award Summary The University of Wisconsin-Madison received a $500,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award supports research focused on delivering a novel immune inhibitory transgene to vascular composite allografts during normothermic preservation to decrease rejection following transplantation. This research addresses a critical...
- The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $406,776.00 to Baylor University to develop a novel graft-localized drug delivery platform for reducing innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation. The 2-year project, spanning September 2024 to September 2026, aims to advance innovative biomedical research solutions to improve health outcomes for military service members and the general public. The funding will support Baylor University's research and development efforts to create a targeted drug delivery system for transplant procedures, with the goal of reducing complications and improving patient recovery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $406.8k | 6/7/24 |